These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25308301)

  • 1. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.
    Bourantas CV; Serruys PW; Nakatani S; Zhang YJ; Farooq V; Diletti R; Ligthart J; Sheehy A; van Geuns RJ; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Rapoza R; Veldhof S; Onuma Y; Garcia-Garcia HM
    EuroIntervention; 2015 Nov; 11(7):746-56. PubMed ID: 25308301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities.
    Simsek C; Karanasos A; Magro M; Garcia-Garcia HM; Onuma Y; Regar E; Boersma E; Serruys PW; van Geuns RJ
    EuroIntervention; 2016 Jan; 11(9):996-1003. PubMed ID: 25349042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study.
    Bourantas CV; Papafaklis MI; Kotsia A; Farooq V; Muramatsu T; Gomez-Lara J; Zhang YJ; Iqbal J; Kalatzis FG; Naka KK; Fotiadis DI; Dorange C; Wang J; Rapoza R; Garcia-Garcia HM; Onuma Y; Michalis LK; Serruys PW
    JACC Cardiovasc Interv; 2014 Mar; 7(3):315-24. PubMed ID: 24529931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial.
    Bourantas CV; Farooq V; Zhang Y; Muramatsu T; Gogas BD; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Ormiston J; Whitbourn R; Dorange C; Rapoza R; Onuma Y; Garcia-Garcia HM; Serruys PW
    EuroIntervention; 2015 Mar; 10(11):1299-306. PubMed ID: 24769420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?
    Brugaletta S; Radu MD; Garcia-Garcia HM; Heo JH; Farooq V; Girasis C; van Geuns RJ; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Rapoza R; Miquel-Hebert K; Ormiston J; Serruys PW
    Atherosclerosis; 2012 Mar; 221(1):106-12. PubMed ID: 22209268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry.
    Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.
    Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C
    JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between inflammatory biomarkers and neointimal response following elective implantation of the ABSORB bioresorbable vascular scaffold.
    Rampat R; Williams T; Mayo T; Mengozzi M; Ghezzi P; Hildick-Smith D; Cockburn J
    Coron Artery Dis; 2019 May; 30(3):183-187. PubMed ID: 30676384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of "plaque/media" change on three modalities of IVUS immediately after implantation of either everolimus-eluting bioresorbable vascular scaffold or everolimus-eluting metallic stent in Absorb II study.
    Zeng Y; Cavalcante R; Tenekecioglu E; Suwannasom P; Sotomi Y; Collet C; Abdelghani M; Jonker H; Digne F; Horstkotte D; Zehender M; Indolfi C; Saia F; Fiorilli R; Chevalier B; Bolognese L; Goicolea J; Nie S; Onuma Y; Serruys PW;
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):441-449. PubMed ID: 28012050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
    Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
    Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.
    Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E
    EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
    Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
    Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neointimal response to everolimus-eluting bioresorbable scaffolds implanted at bifurcating coronary segments: insights from optical coherence tomography.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):169-175. PubMed ID: 27757563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.